Fulgent Genetics, Inc. (FLGT) vs Personalis, Inc. (PSNL)

Fulgent Genetics, Inc. and Personalis, Inc. are both Diagnostics & Research companies. Personalis, Inc. is the larger, with a market value of $1.7B against $513.4M — 3.3× the size. Personalis, Inc. grew revenue faster over the last twelve months: 16.9% against 4.67%. Fulgent Genetics, Inc. has the higher net margin (−27.5% vs −147.7%) and the higher return on invested capital (−8.22% vs −358.4%). Across the 17 metrics below, Fulgent Genetics, Inc. leads on 12 and Personalis, Inc. on 5.

Valuation

Metric FLGT PSNL Diagnostics & Research median
P/E n/m n/m 34.52
P/S 1.56 20.71 4.24
P/B 0.52 7.86 3.42
Price to free cash flow n/m n/m 33.51
EV/EBITDA n/m n/m 23.44
EV/Sales 0.85 18.57 5.18
Earnings yield (16.56%) (7.50%) (1.50%)
Free cash flow yield (1.09%) (6.35%) 0.00%

Profitability

Metric FLGT PSNL Diagnostics & Research median
Gross margin 33.82% 16.71% 48.32%
Operating margin (39.20%) (156.66%) (5.68%)
Net margin (27.53%) (147.74%) (4.10%)
Free cash flow margin 4.37% (120.79%) 0.00%
Return on equity (8.64%) (62.14%) 0.00%
Return on assets (7.93%) (44.66%) (6.05%)
Return on invested capital (8.22%) (358.37%) 0.00%

Growth

Metric FLGT PSNL Diagnostics & Research median
Revenue growth (TTM) 4.67% 16.88% 8.99%
EPS growth (last fiscal year) (39.72%) 33.58% 20.36%
Revenue growth, 5-year CAGR (5.21%) (2.40%) 7.30%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FLGT PSNL Diagnostics & Research median
Debt to equity 0.00 0.00 0.01
Current ratio 5.34 4.53 2.27
Net debt to EBITDA 4.66 2.93 0.68

Dividend

Metric FLGT PSNL Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric FLGT PSNL Diagnostics & Research median
Market cap 513.43m 1.69b 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack